Events

The starting date, date of arrival of the participants is set at Sunday 1 September 2024.

The venue is NH Hotel Bloom in Brussels. The hotel is situated at walking distance from the centre of Brussels so participants can go to the city in the evening and have a meal at their own discretion.

On Wednesday 4 September we will organize a social event in the afternoon including a dinner in the evening.

On the final Thursday evening we will provide a friendship dinner in the hotel or elsewhere. The social event on Wednesday and the friendship dinner at the last evening are both part of the summer school.

The number of participants is set at 25 patients from the membership of Europa Uomo.

The 2024 General Assembly of Europa Uomo will be held on Friday 24th of May in Milan, Italy.

The official language of the General Assembly is English. The meeting includes:

• The presentation of the Board’s Report for the year
• The approval of the accounts and budget
• The election of members to the Board of Europa Uomo. At the GA 2024, there are three incumbents who have finished their first three-year term and are possibly up for reelection.
• A Masterclass on Friday afternoon, May 24th, 2024.

Led by Cosimo Pieri (IT) and Tania Estapé (ES) – Board members Europa Uomo
Speakers: Prof. M. Tsiknakis, Prof. D. Regge, Dr. N. Papanikolaou

Programme:
– Welcome / Introduction by Mr. C. Pieri
– “ProCancer-I Project: Platform and AI Tools” by Prof. M. Tsiknakis
– “What issues are clinicians confronted with, in order to have an accurate diagnosis and treatment for prostate cancer” by Prof. D. Regge
– “AI-based models for prostate cancer management: ProCAncer-I Experience” by Dr. N. Papanikolaou
– Q@A

Tuesday, 7 November 2023 from 18:30 – 19:30 CET.

This UROwebinar will comprise three presentations that provide comprehensive state-of-the-art information on currently available therapies for hormone-naïve prostate cancer (HNPC) and castration-resistant prostate cancer (CRPC).

The therapies will include androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPI), chemotherapy, radioligand, and poly (ADP-ribose) polymerase (PARP) inhibitors

Moderator and speaker: Prof. B. Tombal (BE). Fellow speakers: Prof. Dr. C. Gratzke (DE) and Dr. C. Thibault (FR)